The following is from Josh Hayes…
Josh Hayes will compete in the 82nd running of the Daytona 200 aboard the CSU OneCure Yamaha YZF-R6. Already the winningest rider in American road racing history, Josh will be fighting to finally take the top step at the historic race while also promoting CSU One Cure’s mission to fight cancer in both humans and their pets.
Josh Hayes comes to Daytona after a fantastic 2023 season in MotoAmerica’s ultra-competitive Supersport class where he secured third place in the championship with two wins and eight total visits to the podium. While he currently has no solid plans for racing in 2024, he hasn’t ruled it out if the opportunity arises.
Josh Hayes:“I think by now it’s clear that I love racing motorcycles, and I’m grateful for every opportunity I get to race my Yamaha YZF-R6. I’m excited to grid up and see if we can make it to the front in 200 miles. It’s an honor to help promote the mission of CSU One Cure along the way. I’ve taken my training very seriously this winter, and I know I’m arriving in Daytona with the same preparation as when I was a factory Superbike racer.”
Dr. Christine Hardy, One Cure Program Lead, Flint Animal Cancer Center:
“One Cure is deeply committed to conquering cancer in all species. The only way we can do that is through cutting-edge clinical trials that push for better diagnostics, treatments, and ultimately, outcomes for people and pets. Two Wheels One Cure is helping us race toward a cure by raising awareness and funds for this work. We simply could not do this without the support of our friends who dare to reach new speeds and milestones. We thank the entire team for racing with us.”
Besides One Cure, Josh would also like to thank all the other people and organizations that have made this adventure possible: The Pierce Family, The Trails Preservation Alliance, J4orce Training, Maxima, Dunlop Tires, Evan Steel Performance, Yamaha, RS Taichi, Arai, TCX, Speedcell, GHD Designs, Quinn Knives, and M4 exhausts.
About CSU One Cure:
The One Cure program is founded on the principle that cancer affects all creatures and that breakthroughs come when scientists, veterinarians, and doctors collaborate on treatments for both people and pets. One Cure’s goal is to raise awareness and funding to support the Flint Animal Cancer Center’s clinical trials program and other comparative oncology research. The One Cure clinical trials program is one of the largest in veterinary medicine and includes seven dedicated staff members. In 2023, the program managed 31 clinical trials to study more effective therapies for a variety of cancer types including osteosarcoma, lymphoma, soft tissue sarcoma, and more.
